FIBROSIX INC.
EAST LANSING, MI · Biotech · Defunct
Novel anti-fibrotic small molecule compounds targeting cytokine-mediated hyper-inflammation
fibrosix.com →- Grants
- $861K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice | $302,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice | $2,500 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Quieting systemic hyper-inflammation (COVID-19) | $256,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1356 | FoodSource Lure Corporation | — | — |
| 1357 | TANDA BIOTECH CORPORATION | — | — |
| 1358 | Cerevance | — | — |
| 1359 | FIBROSIX INC. | — | — |
| 1360 | PARAMITA THERAPEUTICS, INC. | — | — |
| 1361 | Abceutics | — | — |
| 1362 | Irex Pharma LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.